Seattle, WA, United States of America

Peter De Vries

This inventor holds 2 USPTO granted patents. Top assignee: Cell Therapeutics, Inc.. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter De Vries. Retrieved from https://idiyas.com/inventor/peter-de-vries-9rbdmlci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter De Vries

Introduction

Peter De Vries is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of therapeutic agents, particularly through his innovative work in conjugates. With a total of 2 patents, his inventions have the potential to impact medical treatments significantly.

Latest Patents

Peter De Vries holds two notable patents. The first is titled "Polyglutamic acid-camptothecin conjugates and methods of preparation." This invention provides polyglutamic acid-therapeutic agent conjugates and outlines methods for their preparation and use. The second patent is similar in nature, also focusing on polyglutamic acid-camptothecin conjugates and their preparation methods. These patents highlight his dedication to advancing therapeutic solutions.

Career Highlights

Peter De Vries is currently associated with Cell Therapeutics, Inc., where he continues to innovate in the field of drug development. His work is characterized by a commitment to improving therapeutic efficacy through novel conjugate technologies.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues, including Rama Bhatt and J. Peter Klein. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Peter De Vries exemplifies the spirit of innovation in the field of therapeutic agents. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…